Lates News

Ensysce Biosciences (ENSC.US): The revenue in the 2025 Q3 financial report reached $493,100, the previous value was $3.419 million, and the expected value was $1.39932 million; Earnings per share was -$1.29, the previous value was $1.00, and the expected value was -$0.90.